Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 148,823 |
|
|||||
| News | - | ||||||
| Day High | 1.70 | Low High |
|||||
| Day Low | 1.62 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Reneo Pharmaceuticals Inc | RPHM | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.10 | -5.88% | 1.60 | 23:00:07 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.67 | 1.62 | 1.70 | 1.66 | 1.70 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,152 | 148,823 | US$ 1.67 | US$ 248,440 | - | 0.9801 - 9.21 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:09:25 | 1 | US$ 1.60 | USD |
Reneo Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 55.3M | 33.31M | - | 0 | -77.39M | -2.32 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Reneo Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RPHM Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.69 | 1.89 | 1.62 | 1.72 | 143,559 | -0.09 | -5.33% |
| 1 Month | 1.61 | 1.93 | 1.61 | 1.75 | 120,925 | -0.01 | -0.62% |
| 3 Months | 1.68 | 1.93 | 1.42 | 1.65 | 248,849 | -0.08 | -4.76% |
| 6 Months | 1.26 | 1.93 | 0.9801 | 1.51 | 659,116 | 0.34 | 26.98% |
| 1 Year | 7.98 | 9.21 | 0.9801 | 2.75 | 422,916 | -6.38 | -79.95% |
| 3 Years | 12.20 | 12.78 | 0.9801 | 3.48 | 182,978 | -10.60 | -86.89% |
| 5 Years | 15.30 | 16.83 | 0.9801 | 3.77 | 178,245 | -13.70 | -89.54% |
Reneo Pharmaceuticals Description
| Reneo Pharmaceuticals Inc is a clinical stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes. |
